Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2

This publication has 34 references indexed in Scilit:

• Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor Interactions
  Journal of Medicinal Chemistry, 2003
• Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER α
  International Journal of Cancer, 2003
• Recognition of Resveratrol by the Human Estrogen Receptor-Alpha: A Molecular Modeling Approach to Understand Its Biological Actions
  Medical Principles and Practice, 2002
• Dominant Negative ER Induces Apoptosis in GH4 Pituitary Lactotrope Cells and Inhibits Tumor Growth in Nude Mice
  Endocrinology, 2001
• Differential activation of wild-type and variant forms of estrogen receptor α by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements
  The Journal of Steroid Biochemistry and Molecular Biology, 2001
• Effects of Multiple Estrogen Responsive Elements, Their Spacing, and Location on Estrogen Response of Reporter Genes
  Molecular Endocrinology, 1997
• Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor
  The Journal of Steroid Biochemistry and Molecular Biology, 1997
• Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
  Science, 1997
• Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue
  Cancer Letters, 1995
• Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1982